Othmar G. Engelhardt

3.7k citations

58 papers · 2.6k indexed · 1 hit paper · h-index 25

Co-authors: Ervin Fodor Adolfo Garcı́a-Sastre Peter Palese George G. Brownlee Matt Smith Stephan Pleschka Otto Haller James S. Robertson
Topics: Influenza Virus Research Studies (45 papers)Respiratory viral infections research (34 papers)Viral gastroenteritis research and epidemiology (14 papers)
Cited by: Epidemiology Infectious Diseases Agronomy and Crop Science
Journals: Proceedings of the National Academy of Sciences PLoS ONE Journal of Virology
Partner nations: United Kingdom United States Germany

In The Last Decade

Othmar G. Engelhardt

56 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rescue of Influenza A Virus from Recombinant DNA

1999 647 citations Ervin Fodor, Othmar G. Engelhardt et al. profile →

Peers

Countries citing papers authored by Othmar G. Engelhardt

Since Specialization

Citations

This map shows the geographic impact of Othmar G. Engelhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Othmar G. Engelhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Othmar G. Engelhardt more than expected).

Fields of papers citing papers by Othmar G. Engelhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Othmar G. Engelhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Othmar G. Engelhardt. The network helps show where Othmar G. Engelhardt may publish in the future.

Co-authorship network of co-authors of Othmar G. Engelhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Othmar G. Engelhardt. A scholar is included among the top collaborators of Othmar G. Engelhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Othmar G. Engelhardt. Othmar G. Engelhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies 2025 ·Frontiers in Immunology ·(unknown),(unknown),(unknown),Fan Zhou,Martin Beukema,Joanna Waldock,Simon P. Jochems,Niels L. Mulder,Cécile A. C. M. van,Othmar G. Engelhardt,Nathalie Mantel,(unknown),Karl A. Brokstad,Agnete S. T. Engelsen,Rebecca Jane Cox,Barbro N. Melgert,Anke Huckriede,Puck B. van Kasteren	6
2	Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK 2024 ·Influenza and Other Respiratory Viruses ·Joanna Waldock,Rebecca Jane Cox,Othmar G. Engelhardt,Stephanie Ascough,Albert Osterhaus,Guus F. Rimmelzwaan,Martin Ludlow,John S. Tregoning,Jacqueline U. McDonald,Ursula J. Buchholz,Rienk E. Jeeninga,Charles Sande,(unknown)	0
3	Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display 2021 ·Scientific Reports ·Tiziano Gaiotto,(unknown),(unknown),Paul Risley,George Carnell,Nigel Temperton,Othmar G. Engelhardt,Simon E. Hufton	23
4	Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model 2020 ·Vaccine ·Kate Guilfoyle,Diane Major,(unknown),Heather James,(unknown),Charlotta Polacek,Ria Lassaunière,Othmar G. Engelhardt,Anders Fomsgaard	11
5	Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity 2020 ·Frontiers in Immunology ·(unknown),Matthew D. Smith,(unknown),Paul Risley,Nigel Temperton,Othmar G. Engelhardt,Mary Collins,Yasuhiro Takeuchi,Simon E. Hufton	23
6	Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines 2019 ·Influenza and Other Respiratory Viruses ·Florian Krammer,Jerry P. Weir,Othmar G. Engelhardt,Jacqueline M. Katz,Rebecca Jane Cox	53
7	Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization 2019 ·Frontiers in Immunology ·(unknown),Wei Dong,Inta Gribonika,(unknown),Tjarko Meijerhof,Jacqueline de Vries‐Idema,Stephen Norley,Kate Guilfoyle,(unknown),Othmar G. Engelhardt,Louis Boon,Dennis Christensen,Nils Lycke,Anke Huckriede	17
8	Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines 2018 ·Frontiers in Immunology ·Wei Dong,(unknown),(unknown),Tjarko Meijerhof,Kate Guilfoyle,Othmar G. Engelhardt,Louis Boon,Cornelis A. M. de Haan,George Carnell,Nigel Temperton,Jacqueline de Vries‐Idema,David J. Kelvin,(unknown)	27
9	Workshop report: Experimental animal models for universal influenza vaccines 2018 ·Vaccine ·Flavia D’Alessio,Gerrit Koopman,Sophie Houard,Edmond J. Remarque,N. Stockhofe,Othmar G. Engelhardt	5
10	Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study 2018 ·Vaccine ·Jacqueline U. McDonald,Peter Rigsby,(unknown),Othmar G. Engelhardt	28
11	Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23–24 August 2016 2017 ·Vaccine ·Justin R. Ortiz,Julian Hickling,Rebecca Jones,Armen Donabedian,Othmar G. Engelhardt,Jacqueline M. Katz,Shabir A. Madhi,Kathleen M. Neuzil,Guus F. Rimmelzwaan,James F. Southern,David Spiro,Joachim Hombach	16
12	CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement 2016 ·Influenza and Other Respiratory Viruses ·Peter Horby,Karen Laurie,Benjamin J. Cowling,Othmar G. Engelhardt,Katharine Sturm‐Ramirez,José L. Sánchez,Jacqueline M. Katz,Timothy M. Uyeki,John Wood,Maria D. Van Kerkhove	29
13	The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein 2016 ·PLoS ONE ·Carolyn Nicolson,Ruth Harvey,Othmar G. Engelhardt,James S. Robertson	4
14	Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity 2015 ·Vaccine ·Maryna C. Eichelberger,Laura Couzens,Yonghong Gao,Min Z. Levine,Jacqueline M. Katz,Ralf Wagner,Catherine Thompson,Katja Höschler,Karen Laurie,Tian Bai,Othmar G. Engelhardt,John Wood	24
15	The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy 2012 ·Influenza and Other Respiratory Viruses ·Maria D. Van Kerkhove,Eeva Broberg,Othmar G. Engelhardt,John Wood,Angus Nicoll	31
16	Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards 2012 ·Biologicals ·Ruth Harvey,(unknown),James S. Robertson,Philip D. Minor,(unknown),Jerry P. Weir,Hitoshi Takahashi,(unknown),Shigeyuki Itamura,(unknown),(unknown),Othmar G. Engelhardt	18
17	Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14 2012 ·PLoS ONE ·Rachel Johnson,(unknown),Ruth Harvey,Carolyn Nicolson,James S. Robertson,Othmar G. Engelhardt	3
18	Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1) 2008 ·Vaccine ·Ruth Harvey,Jun X. Wheeler,(unknown),James S. Robertson,Othmar G. Engelhardt	49
19	Influenza virus inhibits RNA polymerase II elongation 2006 ·Virology ·Annie Chan,Frank T. Vreede,Matt Smith,Othmar G. Engelhardt,Ervin Fodor	65
20	Functional association between viral and cellular transcription during influenza virus infection 2006 ·Reviews in Medical Virology ·Othmar G. Engelhardt,Ervin Fodor	100

About Othmar G. Engelhardt

Othmar G. Engelhardt is a scholar working on Epidemiology, Infectious Diseases and Immunology, having authored 58 papers that have together received 2.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (45 papers), Respiratory viral infections research (34 papers) and Viral gastroenteritis research and epidemiology (14 papers). The work is most often cited by research in Epidemiology (2.0k citations), Infectious Diseases (766 citations) and Agronomy and Crop Science (375 citations). Othmar G. Engelhardt has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Ervin Fodor, Adolfo Garcı́a-Sastre, Peter Palese, George G. Brownlee, Matt Smith, Stephan Pleschka, Otto Haller, James S. Robertson, Thomas Zürcher and Ruth Harvey. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact